Piersilvio Gerometta

Humanitas Gavazzeni

Papers

2

Total Citations

19

H-Index

2

About

Dr. Piersilvio Gerometta is a pioneering cardiothoracic surgeon whose research focuses on advancing minimally invasive and robotic-assisted cardiac procedures, particularly for complex arrhythmias and valvular disease. His major contributions lie in the development and evaluation of hybrid ablation techniques for persistent atrial fibrillation, a challenging condition where conventional pulmonary vein isolation often falls short. In his landmark 2024 study, Dr. Gerometta reported the first European experience with robotic-assisted epicardial hybrid ablation combined with left atrial appendage closure, demonstrating a novel, integrated approach that has already garnered 12 citations for its clinical significance. He has also been instrumental in assessing the safety and effectiveness of robotic-assisted mitral valve surgery, as shown in his 2022 cohort study of 59 patients, which achieved 7 citations and helped validate the use of fourth-generation DaVinci X platforms in a contemporary setting. With a career dedicated to refining surgical robotics and hybrid strategies, Dr. Gerometta’s work is shaping the future of cardiac surgery, offering patients less invasive options with improved outcomes.

Research Focus

Key Achievements

2
H-Index
2
Papers
19
Total Citations
10
Avg Citations/Paper
🏆 Most Cited Paper
Robotic-Assisted Epicardial Hybrid Ablation and Left Appendage Closure in Persistent Atrial Fibrillation: First European Experience
12 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Humanitas Gavazzeni

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago